The enigma of anti-inflammatory therapy for the management of heart failure

Cardiovasc Res. 2020 Jan 1;116(1):6-8. doi: 10.1093/cvr/cvz270.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • C-Reactive Protein*
  • Chronic Disease
  • Heart Failure*
  • Humans
  • Phenotype

Substances

  • Anti-Inflammatory Agents
  • C-Reactive Protein